
|Articles|July 1, 2001
The American Journal of Managed Care
- July 2001
- Volume 7
- Issue 7
Economic Evaluation of Lamivudine Compared with Interferon-Alpha in the Treatment of Chronic Hepatitis B in the United States
Advertisement
Articles in this issue
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Related Content
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Oral Semaglutide as First GLP-1 Pill for Weight Loss
2
Top 5 Most-Read Mental Health Content of 2025
3
Real-World Data Highlight Favorable Responses to Liso-Cel for R/R CLL
4
Baricitinib Shows Real-World Effectiveness in Severe Alopecia Areata Hair Loss
5







































